Skip to main content

Nanomaterials in controlled drug release

Cytotechnology volume 63, pages 319–323 (2011)Cite this article

Abstract

In past years with the advances of chemistry and material sciences, the development of nanotechnology brought generations of nanomaterials with specific biomedical properties. These include the nanoparticle-based drug delivery, nanosized drugs, and nanomaterials for tissue engineering. The present article focuses on the use of nanomaterials in controlled drug release. The applications of nanomaterials with nano-enabled drug release characteristics brought many benefits when compared to the traditional (bulk) materials. We discuss the current advances and propose some future directions for the technology development.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Reference

  • Alexander JJ, Hauswirth WW (2008) Adeno-associated viral vectors and the retina. Adv Exp Med Biol 613:121–128

    Article  CAS  Google Scholar 

  • Al-Ghananeem AM, Saeed H, Florence R, Yokel RA, Malkawi AH (2010) Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses. J Drug Target 18:381–388

    Article  CAS  Google Scholar 

  • Ali J, Ali M, Baboota S, Sahani JK, Ramassamy C, Dao L, Bhavna (2010) Potential of nanoparticulate drug delivery systems by intranasal administration. Curr Pharm Des 16(14):1644–1653

    Article  CAS  Google Scholar 

  • Betbeder D, Spérandio S, Latapie JP, de Nadai J, Etienne A, Zajac JM, Francés B (2000) Biovector nanoparticles improve antinociceptive efficacy of nasal morphine. Pharm Res 17:743–748

    Article  CAS  Google Scholar 

  • Blasi P, Schoubben A, Giovagnoli S, Rossi C, Ricci M (2009) Lipid nanoparticles for drug delivery to the brain: in vivo veritas. J Biomed Nanotechnol 5:344–350

    Article  CAS  Google Scholar 

  • Bok D (2004) Gene therapy of retinal dystrophies: achievements, challenges and prospects. Novartis Found Symp 255:4–12 discussion -6, 177–178

    Article  CAS  Google Scholar 

  • Buch PK, Bainbridge JW, Ali RR (2008) AAV-mediated gene therapy for retinal disorders: from mouse to man. Gene Ther 15:849–857

    Article  CAS  Google Scholar 

  • Caruso G, Raudino G, Caffo M, Alafaci C, Granata F, Lucerna S, Salpietro FM, Tomasello F (2010) Nanotechnology platforms in diagnosis and treatment of primary brain tumors. Recent Pat Nanotechnol 4(2):119–124

    Google Scholar 

  • Charlton S, Jones NS, Davis SS, Illum L (2007) Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device. Eur J Pharm Sci 30:295–302

    Article  CAS  Google Scholar 

  • Chekhonin VP, Baklaushev VP, Iusubalieva GM (2009) Prospects for targeted therapy for gliomas. Vestn Ross Akad Med Nauk (4):30–42

  • Collier JH, Rudra JS, Gasiorowski JZ, Jung JP (2010) Multi-component extracellular matrices based on peptide self-assembly. Chem Soc Rev 39:3413–3424

    Article  CAS  Google Scholar 

  • Denora N, Trapani A, Laquintana V, Lopedota A, Trapani G (2009) Recent advances in medicinal chemistry and pharmaceutical technology–strategies for drug delivery to the brain. Curr Top Med Chem 9:182–196

    Article  CAS  Google Scholar 

  • Ellis-Behnke RG, Liang YX, Tay DK, Kau PW, Schneider GE, Zhang S, Wu W, So KF (2006a) Nano hemostat solution: immediate hemostasis at the nanoscale. Nanomedicine 2:207–215

    CAS  Google Scholar 

  • Ellis-Behnke RG, Liang YX, You SW, Tay DK, Zhang S, So KF, Schneider GE (2006b) Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci USA 103:5054–5059

    Article  CAS  Google Scholar 

  • Fisher RS, Ho J (2002) Potential new methods for antiepileptic drug delivery. CNS Drugs 16:579–593

    Article  CAS  Google Scholar 

  • Fonseca SB, Pereira MP, Kelley SO (2009) Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv Drug Deliv Rev 61:953–964

    Article  CAS  Google Scholar 

  • Gilmore JL, Yi X, Quan L, Kabanov AV (2008) Novel nanomaterials for clinical neuroscience. J Neuroimmune Pharmacol 3:83–94

    Article  Google Scholar 

  • Graf A, McDowell A, Rades T (2009) Poly(alkylcyanoacrylate) nanoparticles for enhanced delivery of therapeutics—is there real potential? Expert Opin Drug Deliv 6:371–387

    Article  CAS  Google Scholar 

  • Grieger JC, Samulski RJ (2005) Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. Adv Biochem Eng Biotechnol 99:119–145

    CAS  Google Scholar 

  • Guo J, Su H, Zeng Y, Liang YX, Wong WM, Ellis-Behnke RG, So KF, Wu W (2007) Reknitting the injured spinal cord by self-assembling peptide nanofiber scaffold. Nanomedicine 3:311–321

    CAS  Google Scholar 

  • Heilbronn R, Weger S (2010) Viral vectors for gene transfer: current status of gene therapeutics. Handb Exp Pharmacol (197):143–170

  • Huynh NT, Passirani C, Saulnier P, Benoit JP (2009) Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm 379:201–209

    Article  CAS  Google Scholar 

  • Jatariu A, Peptu C, Popa M, Indrei A (2009) Micro- and nanoparticles—medical applications. Rev Med Chir Soc Med Nat Iasi 113:1160–1169

    Google Scholar 

  • Jogani VV, Shah PJ, Mishra P, Mishra AK, Misra AR (2008) Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting. Alzheimer Dis Assoc Disord 22:116–124

    Article  CAS  Google Scholar 

  • Kateb B, Chiu K, Black KL, Yamamoto V, Khalsa B, Ljubimova JY, Ding H, Patil R, Portilla-Arias JA, Modo M, Moore DF, Farahani K, Okun MS, Prakash N, Neman J, Ahdoot D, Grundfest W, Nikzad S, Heiss JD (2010) Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? Neuroimage 54(Suppl 1):S106–S124

  • Kaur IP, Bhandari R, Bhandari S, Kakkar V (2008) Potential of solid lipid nanoparticles in brain targeting. J Control Release 127:97–109

    Article  CAS  Google Scholar 

  • Khalil NM, Mainardes RM (2009) Colloidal polymeric nanoparticles and brain drug delivery. Curr Drug Deliv 6:261–273

    CAS  Google Scholar 

  • Kopecek J, Yang J (2009) Peptide-directed self-assembly of hydrogels. Acta Biomater 5:805–816

    Article  CAS  Google Scholar 

  • Kumar M, Misra A, Pathak K (2009) Formulation and characterization of nanoemulsion of olanzapine for intranasal delivery. PDA J Pharm Sci Technol 63:501–511

    CAS  Google Scholar 

  • Ling PM, Cheung SW, Tay DK, Ellis-Behnke RG (2011) Using self-assembled nanomaterials to inhibit the formation of metastatic cancer stem cell colonies in vitro. Cell Transplant 20:127–131

    Article  Google Scholar 

  • Ljubimova JY, Fujita M, Ljubimov AV, Torchilin VP, Black KL, Holler E (2008) Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery. Nanomedicine (Lond) 3:247–265

    Article  CAS  Google Scholar 

  • Martin KR, Klein RL, Quigley HA (2002) Gene delivery to the eye using adeno-associated viral vectors. Methods 28:267–275

    Article  CAS  Google Scholar 

  • Mistry A, Glud SZ, Kjems J, Randel J, Howard KA, Stolnik S, Illum L (2009a) Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium. J Drug Target 17:543–552

    Article  CAS  Google Scholar 

  • Mistry A, Stolnik S, Illum L (2009b) Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm 379:146–157

    Article  CAS  Google Scholar 

  • Modi G, Pillay V, Choonara YE (2010) Advances in the treatment of neurodegenerative disorders employing nanotechnology. Ann N Y Acad Sci 1184:154–172

    Article  CAS  Google Scholar 

  • Namdeo M, Saxena S, Tankhiwale R, Bajpai M, Mohan YM, Bajpai SK (2008) Magnetic nanoparticles for drug delivery applications. J Nanosci Nanotechnol 8:3247–3271

    Article  CAS  Google Scholar 

  • Nochi T, Yuki Y, Takahashi H, Sawada S, Mejima M, Kohda T, Harada N, Kong IG, Sato A, Kataoka N, Tokuhara D, Kurokawa S, Takahashi Y, Tsukada H, Kozaki S, Akiyoshi K, Kiyono H (2010) Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat Mater 9:572–578

    Google Scholar 

  • Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C (2004) Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16:437–445

    Google Scholar 

  • Patel MM, Goyal BR, Bhadada SV, Bhatt JS, Amin AF (2009) Getting into the brain: approaches to enhance brain drug delivery. CNS Drugs 23:35–58

    Article  CAS  Google Scholar 

  • Poeschla EM (2003) Non-primate lentiviral vectors. Curr Opin Mol Ther 5:529–540

    CAS  Google Scholar 

  • Provenzale JM, Silva GA (2009) Uses of nanoparticles for central nervous system imaging and therapy. AJNR Am J Neuroradiol 30:1293–1301

    Article  CAS  Google Scholar 

  • Shilpi S, Jain A, Gupta Y, Jain SK (2007) Colloidosomes: an emerging vesicular system in drug delivery. Crit Rev Ther Drug Carrier Syst 24:361–391

    CAS  Google Scholar 

  • Sleeper MM, Bish LT, Sweeney HL (2009) Gene therapy in large animal models of human cardiovascular genetic disease. ILAR J 50:199–205

    CAS  Google Scholar 

  • Surace EM, Auricchio A (2003) Adeno-associated viral vectors for retinal gene transfer. Prog Retin Eye Res 22:705–719

    Article  CAS  Google Scholar 

  • Surace EM, Auricchio A (2008) Versatility of AAV vectors for retinal gene transfer. Vision Res 48:353–359

    Article  CAS  Google Scholar 

  • Suri SS, Fenniri H, Singh B (2007) Nanotechnology-based drug delivery systems. J Occup Med Toxicol 2:16

    Article  Google Scholar 

  • Tosi G, Costantino L, Ruozi B, Forni F, Vandelli MA (2008) Polymeric nanoparticles for the drug delivery to the central nervous system. Expert Opin Drug Deliv 5:155–174

    Article  CAS  Google Scholar 

  • Wong HL, Chattopadhyay N, Wu XY, Bendayan R (2010) Nanotechnology applications for improved delivery of antiretroviral drugs to the brain. Adv Drug Deliv Rev 62:503–517

    Article  CAS  Google Scholar 

  • Zhao X, Pan F, Xu H, Yaseen M, Shan H, Hauser CA, Zhang S, Lu JR (2010) Molecular self-assembly and applications of designer peptide amphiphiles. Chem Soc Rev 39:3480–3498

    Article  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Department of pharmacy, Integrated Chinese and Western Medicine Hospital of Zhejiang Province, 310003, Hangzhou, Zhejiang, China

    Xin-Jun Cai & Ying-Ying Xu

Authors
  1. Xin-Jun Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ying-Ying Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ying-Ying Xu.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Cai, XJ., Xu, YY. Nanomaterials in controlled drug release. Cytotechnology 63, 319–323 (2011). https://doi.org/10.1007/s10616-011-9366-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10616-011-9366-5

Keywords

  • Drug release
  • Nanomaterial
  • Nanoparticle
  • Gel
  • Colloid
  • Drug delivery
  • Self-assembly